IL6 and hemorrhagic disease: Early pro-inflammatory peaks (e.g., IFN-γ, TNF, IL-6) may drive vascular inflammation and tissue damage, contributing to severe clinical signs such as bleeding disorders, where endothelial injury and dysregulated coagulation cascades are involved [19, 22, 36, 37, 59].